Both in Surgical Instruments
GLOBUS MEDICAL vs Insulet
Over the past year GMED returned +28.9% and PODD returned −53.8%; their daily moves had a correlation of 0.28.
GMED +28.9% PODD −53.8%Growth of $1, one year, split-adjusted
| Metric | GMED | PODD |
|---|---|---|
| Price | $81.52 | $150.40 |
| Market cap | $10.95B | $10.43B |
| Today | +0.77% | +0.38% |
| 1 month | +7.7% | +13.2% |
| 6 months | −7.1% | −6.0% |
| Year to date | −6.6% | −47.1% |
| 1 year | +28.9% | −53.8% |
| Revenue growth (YoY) | +5.9% | +23.5% |
| Gross margin | 69.4% | 70.2% |
| Net margin | 19.2% | 11.8% |
| P/E (TTM) | 20.4× | 27.8× |
| Price / sales | 3.5× | 3.4× |
| Net cash | $595.1M | -$413.5M |
| Dividend yield | — | — |
| Volatility (60d) | 28.4% | 55.9% |
| Short % of float | 6.2% | 8.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).